Opinion: Pfizer's Dividend Riskier Than It Looks, Even with a 7% Yield
Pfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
Identify scenarios where active funds may outperform, focusing on market environments, fees, and your risk tolerance.
14,457 articlesPfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
A downgrade and AI chip headlines pushed Broadcom stock lower today. Here’s what happened, what it could mean, and pr...
The second half of 2026 could reward investors who pick AI stock winners with durable competitive advantages. This gu...
A retiree’s hesitation to touch a Roth IRA for fear of higher Medicare costs and Social Security taxes is untrue: qua...
Accenture stock has faced a setback as AI and market shifts weigh on the stock. This guide explains the drivers behin...
A landmark portfolio reshuffle puts Alphabet ahead of Berkshire's long-time Coca-Cola cornerstone. This analysis expl...
Netflix posts solid Q1 growth driven by an ad-supported tier, while Comcast faces margin pressure from sports costs a...
A family of five channeled $100 a month into a long-term Hawaii vacation plan for 12 years, only to face a higher pri...
Strategy launched its largest BTC sale this week, intensifying the debate over unrealized losses among major crypto h...
Oil prices surge as tensions around Iran intensify and the ceasefire appears cracking. Traders weigh supply disruptio...
After eight weeks of net withdrawals, Bitcoin spot ETFs posted a rare inflow week. The swing comes as crypto prices r...
The SEC has launched a public-comment process on novel ETFs, signaling tighter rules for crypto assets and leverage a...